| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/21/2009 | EP1399563B1 Moraxella (branhamella) catarrhalis antigens |
| 01/21/2009 | EP1353691B1 Molecular antigen array presenting amyloid beta |
| 01/21/2009 | EP1333036B1 Peg-modified erythropoietin |
| 01/21/2009 | EP1294906B1 Whole-body optical imaging of gene expression and uses thereof |
| 01/21/2009 | EP1261701B1 FULL-LENGTH INFECTIOUS cDNA CLONES OF TICK BORNE FLAVIVIRUS |
| 01/21/2009 | EP1234880B1 Novel protein tab2 |
| 01/21/2009 | EP1105495B2 Method for producing yeast expressed hpv types 6 and 16 capsid proteins |
| 01/21/2009 | EP1023907B1 Medicinal compositions with cholesterol-lowering effect |
| 01/21/2009 | EP1019438B1 Apoptosis-related compounds and their use |
| 01/21/2009 | EP1007546B1 Molecular mimetics of meningococcal b epitopes |
| 01/21/2009 | EP0975760B1 Motilin homologs |
| 01/21/2009 | EP0951466B1 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds |
| 01/21/2009 | EP0912195B1 Vaccine comprising antigens bound to carriers through labile bonds |
| 01/21/2009 | EP0904276B1 A plant nuclear scaffold attachment region which increases gene expression |
| 01/21/2009 | EP0850053B1 Erythrocytes loaded with s-nitrosothiol and uses therefor |
| 01/21/2009 | CN101351550A Chimaeric fusion protein with superior chaperone and folding activities |
| 01/21/2009 | CN101351475A Interleukin-12p40 variants with improved stability |
| 01/21/2009 | CN101351474A Antimicrobial cathelicidin peptides |
| 01/21/2009 | CN101351473A A polypeptide complex of TRPM8 and calmodulin and its uses thereof |
| 01/21/2009 | CN101351224A Hypoallergenic variants of the major allergen from Betula verrucosa pollen |
| 01/21/2009 | CN101351222A Mannose immunogens for HIV-1 |
| 01/21/2009 | CN101351221A Outer coat protein PA5158 of pseudomonas aeruginosa |
| 01/21/2009 | CN101351216A Compositions comprising IGBPMA and uses thereof |
| 01/21/2009 | CN101348821A High purity sericin powder prepared from silkworm cocoon blaze and preparation thereof |
| 01/21/2009 | CN101348801A Method for preparing animal cellular membrane and cellular organ membrane protein |
| 01/21/2009 | CN101348800A Method for efficiently obtaining animal membrane protein by means of togavirus budding characteristic |
| 01/21/2009 | CN101348793A Insecticidal proteins from bacillus thuringiensis |
| 01/21/2009 | CN101348792A Plant-optimized polynucleotides encoding approximately 15 kDa and approximately 45 kda pesticidal proteins |
| 01/21/2009 | CN101348791A Populus euphratica Oliv hydrotropic gene PeXET and promoter thereof |
| 01/21/2009 | CN101348789A Production of human mutant proteins in human cells by homologous recombination |
| 01/21/2009 | CN101348787A Preparation and use of giant panda Ascaris schroederi antigen |
| 01/21/2009 | CN101348769A H+-ATP enzyme acid resistant gene atpAí» and Lactobacillus casei containing the same |
| 01/21/2009 | CN101348524A Protein stabilization formulations |
| 01/21/2009 | CN101348523A Plants cold-tolerant and drought resisting protein, encoding genes and use thereof |
| 01/21/2009 | CN101348522A Copper resistance binary signal conducting system regulation factor mutant, and construction and use thereof |
| 01/21/2009 | CN101348520A Method for separating and purifying sea-mussel mucin by using mixing adsorption chromatography |
| 01/21/2009 | CN101348519A Preparation technique and use of ricefield eel antibacterial peptide |
| 01/21/2009 | CN100453555C Paddy rice fragile straw controlling gene BC1 and use thereof |
| 01/20/2009 | USRE40624 An isolated nucleic acid encoding the ASKRK polypeptide comprising an amino acid identification sequence #2; nucleotide sequences; expression vector; pancreatic beta host cell. antidiabetic agents; non-insulin dependent diabetes |
| 01/20/2009 | US7479914 A-D converter and A-D convert method |
| 01/20/2009 | US7479579 Genetically engineered rodent comprisingamyloid precursor protein mutation for use as tool in screening therapeutic agents for treatment of neurodegenerative diseases |
| 01/20/2009 | US7479554 AAV5 nucleic acids |
| 01/20/2009 | US7479553 Nucleic acids encoding mutant disulfide bond-stabilized human immunodeficiency virus type 1 (HIV-1) gp140 envelope glycoproteins |
| 01/20/2009 | US7479552 Type-1 ribosome-inactivating protein |
| 01/20/2009 | US7479551 Enhanced membrane binding affinityl blood coagulation |
| 01/20/2009 | US7479549 Recombinant canine thyroid stimulating hormone and methods of production and use thereof |
| 01/20/2009 | US7479547 Using shuffled viral protein sequences as tool in generating antibodies for diagnosis, prevention and treatment of viral disease |
| 01/20/2009 | US7479545 Used as pharmaceuticals, diagnostics, biosensors and bioreactors |
| 01/20/2009 | US7479544 biological conjugated drug binding with a detectable label, or toxin maytansine and calicheamicin; monoclonal antibody as antiinflammatory agents in the therapeutic treatment and diagnostic detection of immune disorders in mammals; biodrugs |
| 01/20/2009 | US7479542 polymer conjugated drug contains polyethylene glycol covalently attached to the polypeptide; biodrug for treating hepatitis C; new kind of interleukins; fusion proteins |
| 01/20/2009 | US7479541 and fusion proteins with green fluorescent protein, used for modulating cell differentiation and apoptosis, including cell formation of tissues |
| 01/20/2009 | US7479540 isolating proteins that have a molecular weight of about 25-30 kDa, bind to anti-light chain antibodies and to adipocytes to promote lipolysis, from the urine or blood of human experiencing weight loss associated with cancer, HIV or inflammation; light chain peptides used in the treatment of obesity |
| 01/20/2009 | US7479539 Hedgehog fusion proteins |
| 01/20/2009 | US7479537 Reagents and methods useful for detecting diseases of the breast |
| 01/20/2009 | US7479484 Peptides and peptidomimetics having immune-modulating, anti-inflammatory, and anti-viral activity |
| 01/20/2009 | US7479482 For treatment of neurodegenerative disorders |
| 01/20/2009 | US7479480 Peptides that promote lipid efflux |
| 01/20/2009 | US7479479 CNGH0010 specific polynucleotides, polypeptides, antibodies, compositions, methods and uses |
| 01/20/2009 | US7479478 Human parathyroid hormone modifications, preparation and use |
| 01/20/2009 | US7479389 Deletions inactivate arginine and histidine biosynthetic pathways in methylotrophic yeast (Pichia pastoris); arginiosuccinate synthase (ARG1); amino-acid N-acetyltransferase (ARG2), ornithine carbamoyltransferase (ARG3), ATP phosphoribosyltransferase (HIS1), histidinol-phosphatase (HIS2) |
| 01/20/2009 | US7479386 Hepatitis X virus for use in generation of antibody and vaccine compositions for use in diagnosis, prevention and treatment viral infection; immunotherapeutic and diagnostics |
| 01/20/2009 | US7479379 Methods for altering protein production rates |
| 01/20/2009 | US7479377 Genetic construct intracellular monitoring system |
| 01/20/2009 | US7479373 Method for identifying compounds modulating taste transduction |
| 01/20/2009 | US7479372 Beta-secretase substrates and uses thereof |
| 01/20/2009 | US7479369 using a nucleic acid molecule in a screening assay for the identification of antiproliferative drug, and performing a functional analysis for the spindle formation or microtubule function during cell division; small interfering RNAs |
| 01/20/2009 | US7479284 Babesia canis vaccine |
| 01/20/2009 | US7479282 Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof |
| 01/20/2009 | US7479281 Locally administering botulinum toxin powder to a patient using a using a needleless syringe connected to a tank of compressed inert gas, such as helium, for producing a supersonic gas flow; gold, platinum, tungsten or ice crystal carrier; pain is alleviated within 1 to 7 days of administration |
| 01/20/2009 | US7479280 Papilloma virus capsid support comprising chimeric lymphocyte epitope for use in identifying modulators to treat and prevention cell proiferative, autoimmune and viral diseases |
| 01/20/2009 | US7479278 Troponin I polypeptide fragments and uses thereof |
| 01/20/2009 | US7479275 Daily intravenous administration of VEGFR1R2-Fc Delta C1 or coadministration with a cytotoxic, chemotherapeutic or antigrowth agent, while gradually decreasing dosage of the antagonist; colorectal cancer |
| 01/20/2009 | US7479274 Daily intravenous administration of VEGFR1R2-Fc Delta C1 or coadministration with a cytotoxic, chemotherapeutic or antigrowth agent, while gradually decreasing dosage of the antagonist; pancreatic cancer |
| 01/20/2009 | US7479273 Method of administering and using VEGF inhibitors for the treatment of renal cell cancer |
| 01/20/2009 | US7479272 Method of administering and using VEGF inhibitors for the treatment of breast cancer |
| 01/20/2009 | US7479270 Methods and compositions for activating VEGF-D and VEGF-C |
| 01/20/2009 | CA2264570C Invasion-inducing agents and invasion-inhibitors for use in wound healing and cancer |
| 01/20/2009 | CA2236263C Methods for use of mpl ligands with primitive human stem cells |
| 01/20/2009 | CA2137822C Method for detecting pre-cancerous or cancerous cells using p90 antibodies or probes |
| 01/20/2009 | CA2108473C Heregulins (hrgs) binding proteins of p185erb2 |
| 01/19/2009 | CA2605130A1 Vaccine composition and uses thereof |
| 01/15/2009 | WO2009009523A2 Prevention of disulfide bond reduction during recombinant production of polypeptides |
| 01/15/2009 | WO2009009493A2 Aegyptin and uses thereof |
| 01/15/2009 | WO2009009399A2 Ixostatins and their use |
| 01/15/2009 | WO2009009396A2 Bri polypeptides and reducing ab aggregation |
| 01/15/2009 | WO2009009086A2 Methods and compositions for inactivating alpha 1,6 fucosyltransferase (fut 8) gene expression |
| 01/15/2009 | WO2009009084A2 Transcriptional engineering of lactobacillus |
| 01/15/2009 | WO2009009034A2 Methods and compositions useful in the treatment of mucositis |
| 01/15/2009 | WO2009009019A2 Treatment and diagnostic methods for fibrosis related disorders |
| 01/15/2009 | WO2009008908A2 Structure-activity relationships |
| 01/15/2009 | WO2009008756A2 DNA SEQUENCE ENCODING A SPECIFIC L-ARABINOSE TRANSPORTER, A cDNA MOLECULE, A PLASMID COMPRISING THE SAID DNA SEQUENCE, HOST CELL TRANSFORMED WITH SUCH PLASMID AND APPLICATION THEREOF |
| 01/15/2009 | WO2009008713A1 Tap-inhibitors from old world primate 1-herpesviruses and their use |
| 01/15/2009 | WO2009007848A2 Bioactive peptides and method of using same |
| 01/15/2009 | WO2009007714A2 Human pancreatic polypeptide (hpp) analogues and their effects on feeding behaviour |
| 01/15/2009 | WO2009007451A1 Purification of factor viii using a mixed-mode or multimodal resin |
| 01/15/2009 | WO2009007326A2 Method for the production of an aqueous glucose solution from corn |
| 01/15/2009 | WO2009007298A2 Allergens from aspergillus versicolor, and method of detecting a mold allergy caused by interior rooms |
| 01/15/2009 | WO2009007244A2 Replication deficient influenza virus for the expression of heterologous sequences |
| 01/15/2009 | WO2009007120A2 Tnf superfamily collectin fusion proteins |
| 01/15/2009 | WO2009006782A1 CLONING TRANSCRIPTION FACTOR GENE OsWOX20 THAT REGULATES THE GROWTH AND DEVELOPMENT OF MONOCOTYLEDON'S ROOT AND USES THEREOF |